13F

Investor

Eleva Capital SAS

CIK 0002054496 · filed 2026-04-15 · SEC filing

13F book

$343.4M

Positions

24

Largest name

81.3%

Crh Plc

Est. mark

Need a prior quarter to estimate
NameTickerSharesValueWeightEst. markChange
Crh Plc2.65M$279.1M81.3%Held
Amer Sports, Inc.AS298.8K$9.84M2.9%Held
Nvidia CorpNVDA52K$9.07M2.6%Held
Netflix IncNFLX87.2K$8.38M2.4%Held
Alphabet Inc28K$8.04M2.3%Held
Taiwan Semiconductor Mfg Ltd21.4K$6.51M1.9%Held
Arista Networks, Inc.ANET47K$5.77M1.7%Held
Amazon Com IncAMZN16.2K$3.36M1.0%Held
T-Mobile Us Inc14.3K$3.01M0.9%Held
Robinhood Mkts Inc31.6K$2.19M0.6%Held
On Hldg Ag50.1K$1.71M0.5%Held
Boston Scientific CorpBSX26.7K$1.67M0.5%Held
Spotify Technology S.A.SPOT2.71K$1.32M0.4%Held
Newamsterdam Pharma Company25.7K$823.3K0.2%Held
CG Oncology, Inc.CGON8.29K$561K0.2%Held
Esperion Therapeutics Inc Ne183K$501.5K0.1%Held
Mineralys Therapeutics, Inc.MLYS17.1K$462.7K0.1%Held
Fennec Pharmaceuticals Inc.FENC53.2K$327.4K0.1%Held
Disc Medicine, Inc.IRON5.12K$327.1K0.1%Held
Viridian Therapeutics Inc7.13K$139.4K0.0%Held
Freeport-Mcmoran IncFCX2.26K$132.7K0.0%Held
Archer Aviation Inc21.5K$111.3K0.0%Held
Edgewise Therapeutics, Inc.EWTX17.5K$55K0.0%Held
Aquestive Therapeutics, Inc.AQST2.72K$11.3K0.0%Held

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.